ATOSSA THERAPEUTICS, INC. Increase (Decrease) in Security Deposits
ATOSSA THERAPEUTICS, INC. (ATOS) reported Increase (Decrease) in Security Deposits of $20.65 thousand for the 12-month period ending 2016-12-31, per its 10-K/A filed 2017-03-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInSecurityDeposits · last filed 2017-03-21
- ATOSSA THERAPEUTICS, INC. increase (decrease) in security deposits for the quarter ending 2014-12-31 was $30.77K, a 28.72% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in security deposits for the quarter ending 2014-09-30 was -$17.65K, a 506.66% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in security deposits for the quarter ending 2014-06-30 was $0.00.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in security deposits for the quarter ending 2014-03-31 was -$24.86K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in security deposits for fiscal 2016 was $20.65K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in security deposits for fiscal 2015 was -$28.14K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in security deposits for fiscal 2014 was -$11.75K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in security deposits for fiscal 2013 was $0.00.
| Period end | Increase (Decrease) in Security Deposits 3 month | Increase (Decrease) in Security Deposits 6 month | Increase (Decrease) in Security Deposits 9 month | Increase (Decrease) in Security Deposits 12 month | Increase (Decrease) in Security Deposits 41 month | Increase (Decrease) in Security Deposits 44 month | Increase (Decrease) in Security Deposits 47 month | Increase (Decrease) in Security Deposits 50 month | Increase (Decrease) in Security Deposits 53 month | Increase (Decrease) in Security Deposits 56 month | Increase (Decrease) in Security Deposits 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $20.65K 10-K/A · filed 2017-03-21 | ||||||||||
| 2015-12-31 | -$28.14K 10-K/A · filed 2017-03-21 | ||||||||||
| 2014-12-31 | $30.77K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $13.12K derived: sum of 2 quarters · filed 2016-03-30 | $13.12K derived: sum of 3 quarters · filed 2016-03-30 | -$11.75K 10-K · filed 2016-03-30 | |||||||
| 2014-09-30 | -$17.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$17.65K derived: sum of 2 quarters · filed 2014-11-12 | -$42.51K 10-Q · filed 2014-11-12 | $648.00 derived: sum of 4 quarters · filed 2015-03-30 | |||||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$24.86K 10-Q · filed 2014-08-12 | $18.30K derived: sum of 3 quarters · filed 2015-03-30 | $22.64K derived: sum of 4 quarters · filed 2015-03-30 | |||||||
| 2014-03-31 | -$24.86K 10-Q · filed 2014-05-14 | $18.30K derived: sum of 2 quarters · filed 2015-03-30 | $22.64K derived: sum of 3 quarters · filed 2015-03-30 | -$24.86K derived: sum of 4 quarters · filed 2015-03-30 | -$61.31K 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | $43.16K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $47.50K derived: sum of 2 quarters · filed 2015-03-30 | $0.00 derived: sum of 3 quarters · filed 2015-03-30 | $0.00 10-K · filed 2015-03-30 | -$36.45K 10-K · filed 2014-03-27 | ||||||
| 2013-09-30 | $4.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$43.16K derived: sum of 2 quarters · filed 2014-11-12 | -$43.16K 10-Q · filed 2014-11-12 | -$41.66K derived: sum of 4 quarters · filed 2014-11-12 | -$79.61K 10-Q · filed 2013-11-12 | ||||||
| 2013-06-30 | -$47.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$47.50K 10-Q · filed 2014-08-12 | -$46.00K derived: sum of 3 quarters · filed 2014-08-12 | -$43.80K derived: sum of 4 quarters · filed 2014-08-12 | -$83.95K 10-Q · filed 2013-08-14 | ||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $1.50K derived: sum of 2 quarters · filed 2014-05-14 | $3.70K derived: sum of 3 quarters · filed 2014-05-14 | $3.70K derived: sum of 4 quarters · filed 2014-05-14 | -$36.45K 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | $1.50K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $3.70K derived: sum of 2 quarters · filed 2014-03-27 | $3.70K derived: sum of 3 quarters · filed 2014-03-27 | -$29.09K 10-K · filed 2014-03-27 | -$36.45K 10-K · filed 2013-03-28 | ||||||
| 2012-09-30 | $2.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $2.20K derived: sum of 2 quarters · filed 2013-11-12 | -$30.59K 10-Q · filed 2013-11-12 | -$30.99K derived: sum of 4 quarters · filed 2013-11-12 | -$37.95K 10-Q/A · filed 2013-01-22 | ||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$32.79K 10-Q · filed 2013-08-14 | -$33.19K derived: sum of 3 quarters · filed 2013-08-14 | ||||||||
| 2012-03-31 | -$32.79K 10-Q · filed 2013-05-15 | -$33.19K derived: sum of 2 quarters · filed 2013-05-15 | |||||||||
| 2011-12-31 | -$400.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | -$2.60K 10-K · filed 2013-03-28 | |||||||||
| 2011-09-30 | -$2.20K 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |